Johnson & Johnson just can't seem to get its consumer health manufacturing in order.
Drugmakers hope to export their success to emerging markets so they can reap big rewards, but Johnson & Johnson's Janssen unit appears to have taken a backward approach in South Korea, where it is in hot water over a recall of Children's Tylenol products.
Johnson & Johnson, whose McNeil Consumer Healthcare is operating under an FDA consent decree, is taking a sales hit this flu season as consumers go to some pharmacies and find few or no Tylenol products on the shelves.
CVS, the drugstore chain, will stop stocking Tylenol in some of its stores. Ongoing supply problems have store shelves still empty, and CVS wants to fill those holes.
Drugmakers, get ready to revise your playbooks. Branded generics may be a no-go in India. Continuing their assault on drug costs, government officials are rolling out a new generics-only licensing policy. New off-patent drugs would win approval under their generic names only.
Improvements being made at a plant in Puerto Rico as Johnson & Johnson ($JNJ) checks off the requirements of a consent decree with the FDA are going to cost nearly 25% of its workers their jobs.
Alex Gorsky, in his first earnings call since taking the CEO spot at Johnson & Johnson, listed a lot of priorities--there is a lot to be fixed at the pharmaceutical and consumer products company--but getting over-the-counter products like Tylenol and Motrin back into the hands of consumers remains his number one "short term priority."
William Weldon really is a piece of work. In January he told analysts the consumer products plant in Fort Washington, PA, would open in 2013.
Manufacturing issues that have led to recalls and product shortages continue to be a drag on the earnings of Johnson & Johnson, but the company saw its first quarter profits rise by double digits.
Johnson & Johnson's consumer healthcare unit is recalling another children's Tylenol product. This time, it's not manufacturing failures spurring the recall, but a dosing system that...